Kewaunee Scientific CORP /DE/ Form 4 insider transactions

Elizabeth D. Phillips, SVP of People & Culture at Kewaunee Scientific Corp, reported transactions involving the sale of company stock and the settlement of restricted stock units.

Mandar Ranade, SVP of IT & Engineering at Kewaunee Scientific Corp, reported equity transactions on June 30, 2026, involving restricted stock units and common stock.

Ryan S. Noble, SVP of Sales & Marketing Dev at Kewaunee Scientific Corp, reported transactions involving restricted stock units and common stock.

Douglas J. Batdorff, SVP of Manufacturing Operations at Kewaunee Scientific Corp, reported significant stock transactions including the acquisition of restricted stock units and the disposal of common stock.

Donald T. Gardner III, Chief Financial Officer of Kewaunee Scientific Corp, reported significant stock transactions including the settlement of restricted stock units and the disposal of shares.

Thomas David Hull III, Director and President & CEO of Kewaunee Scientific Corp, reported significant transactions involving restricted stock units and common stock.

Kewaunee Scientific Corp reports the grant of Restricted Stock Units to SVP, People & Culture Elizabeth D. Phillips.

Mandar Ranade, SVP of IT & Engineering at Kewaunee Scientific Corp, was granted 2,635 restricted stock units on June 24, 2026.

Ryan S. Noble acquired 2,628 restricted stock units of Kewaunee Scientific Corp, with vesting beginning in 2027.

Kewaunee Scientific Corp reports the grant of restricted stock units to SVP, Manufacturing Operations, Douglas J. Batdorff.

Donald T. Gardner III, Chief Financial Officer of Kewaunee Scientific Corp, received 5,428 restricted stock units on June 24, 2026.

Thomas David Hull III, Director and President & CEO of Kewaunee Scientific Corp, was granted 15,195 Restricted Stock Units.

John Jette Campbell, a Director at Kewaunee Scientific Corp, was awarded 2,013 shares of common stock as part of his annual compensation.

Kewaunee Scientific Corp director Keith M. Gehl received a stock award of 2,013 shares as part of his annual compensation.

KEWAUNEE SCIENTIFIC CORP director Margaret B. Pyle gifted 2,750 shares of common stock to her grandchildren on March 26, 2026.

Kewaunee Scientific's President and CEO, Thomas David Hull III, sold 2,177 shares of common stock for approximately $81,637.

Kewaunee Scientific Corp's Chief Financial Officer, Donald T. Gardner III, sold 2,000 shares of common stock for a weighted average price of $37.57 per share.

Kewaunee Scientific Corp's President and CEO, Thomas David Hull III, sold 658 shares of common stock in late December 2025 under a pre-arranged trading plan.

Kewaunee Scientific Corp's President and CEO, Thomas David Hull III, sold 884 shares of common stock for a weighted average price of $38.01 per share under a pre-arranged trading plan.

Kewaunee Scientific Corp. President and CEO Thomas David Hull III sold 1,000 shares of common stock for $39 per share in a pre-planned transaction.

KEWAUNEE SCIENTIFIC CORP's President and CEO, Thomas David Hull III, sold 1,000 shares of common stock for $39 per share on December 17, 2025, under a pre-arranged 10b5-1 plan.

Kewaunee Scientific Corp. CFO Donald T. Gardner III sold 3,000 shares of common stock for a weighted average price of $42.76 per share under a pre-arranged trading plan.

Kewaunee Scientific Corp's VP of Human Resources, Elizabeth D. Phillips, sold 6,880 shares of common stock on October 2, 2025, under a pre-arranged 10b5-1 trading plan.

Kewaunee Scientific Corp's President and CEO, Thomas David Hull III, reported the sale of 1,000 shares of common stock at a weighted average price of $43.09.

Kewaunee Scientific Corp's President and CEO, Thomas David Hull III, sold 1,854 shares of common stock for a weighted average price of $43.42 per share under a pre-arranged trading plan.

Kewaunee Scientific's President and CEO, Thomas David Hull III, reported sales of common stock totaling 1,721 shares under a Rule 10b5-1 plan.

Kewaunee Scientific's President, CEO, and Director, Thomas David Hull III, reported sales of common stock totaling 1,425 shares over two days.

Kewaunee Scientific Director John Jette Campbell received 690 shares of common stock as part of his annual compensation.

Kewaunee Scientific Corp. Director Margaret B. Pyle reported gifting 325 shares of common stock to a grandchild.

Kewaunee Scientific Corporation's Chief Financial Officer, Donald T. Gardner III, sold 3,000 shares of common stock for approximately $175,806.56 through pre-arranged transactions.